Lo: How Should Vaccines Be Financed?
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
This page contains recent media, interviews, and conference appearances by FSAS affiliated faculty and researchers
By
An MIT startup showcase featured smart underwear, social networks for women, and a law enforcement collaboration tool.
By
From alternative fuels and next-gen batteries to compact fusion and carbon capture, here is a sampling of clean tech companies with ties to MIT.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
The clean-tech startup is developing new membrane technology for separating industrial gases and vapors.
By
Hackathon is open to the public and will take place November 6-8, 2020
By
The founder of the Martin Trust Center for MIT Entrepreneurship is recognized for a lifetime of pioneering entrepreneurship.
The Food Supply Chain Analytics and Sensing (FSAS) Initiative is creating predictive analytical tools and technologies to improve the design and management of safe and reliable food supply chains